CPAP Recall

Providing support for the Philips CPAP and Bi-Level PAP Devices Recall

Activating on the recall is a priority for you and we strongly encourage you to take action if you haven’t already.

 

The quickest way is to register your CPAP machine with Philips for the recall is by following this link philips.com.au/healthcare/e/sleep/communications/src-update

If your machine is affected by the recall, Phillips will let you know and confirm the next steps.

 

We are here to help and therefore if you need assistance with the recall process we can provide a consultation free of charge. Sleep apnoea can be a stressful health condition at the best of times and therefore you may require any of the following:

  • Download data from your CPAP machine
  • Develop a revised management plan
  • Provide supporting information to your GP and/or specialist
  • Act on your behalf to process the registration of your CPAP machine for recall

We invite you to make an appointment to discuss your next steps.

 

Phone: 03 5442 0444 (Health Hub direct line)

Drop in: 379 Hargreaves Street, Bendigo (only)

Updated 27 August 2021

 

Philips CPAP and Bi-Level PAP Devices Recall

A notice from Philips Electronics Australia Ltd.

Following consultation with the TGA, is undertaking a product defect correction for the 14 sleep and respiratory care devices they manufacture. This is in response to risks posed by the polyester-based polyurethane (PE-PUR) sound abatement foam component in these goods.

Philips has identified that the foam used in the blower boxes of their continuous and non-continuous ventilators may degrade into particles, which may enter the devices’ air pathway and be ingested or inhaled by the user, and release certain chemicals as gases. The foam may degrade more quickly if the device is cleaned using unapproved cleaning methods, such as ozone gas products.

Where possible, Philips will replace the sound abatement foam in affected devices. If this is not possible, a replacement device will be provided.

A patient-specific risk assessment may be needed to determine whether the benefits of continuing therapy outweighs the risks identified.

Bendigo UFS understand that the current CPAP and Bi-Level PAP device recall will cause some distress and discomfort to patients. We are currently working with the appropriate authorities to ensure that our patients health care is at the front of mind with little disruptionCurrent UFS Pharmacies Sleep Apnoea patients will be contacted directly with information and the relevant next steps. 

We thank you for your patience as we continue to support you.

Updated 8 July 2021